{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:04:14Z","timestamp":1770750254785,"version":"3.50.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41409-022-01730-6","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T08:02:54Z","timestamp":1654329774000},"page":"1382-1388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-7913","authenticated-orcid":false,"given":"Masaharu","family":"Tamaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Matsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9315","authenticated-orcid":false,"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunto","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Misaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8013-1400","authenticated-orcid":false,"given":"Kazuki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Gomyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Tanihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko","family":"Kusuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-8526","authenticated-orcid":false,"given":"Shun-ichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2635-3395","authenticated-orcid":false,"given":"Shinichi","family":"Kako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4866-9307","authenticated-orcid":false,"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,4]]},"reference":[{"key":"1730_CR1","doi-asserted-by":"publisher","unstructured":"Bergeron A, Chevret S, Peffault de Latour R, Chagnon K, de Margerie-Mellon C, Rivi\u00e8re F, et al. Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation. Eur Respir J. 2018;51. https:\/\/doi.org\/10.1183\/13993003.02617-2017","DOI":"10.1183\/13993003.02617-2017"},{"key":"1730_CR2","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.bbmt.2019.06.004","volume":"25","author":"L Broglie","year":"2019","unstructured":"Broglie L, Fretham C, Al-Seraihy A, George B, Kurtzberg J, Loren A, et al. Pulmonary Complications in Pediatric and Adolescent Patients Following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transpl. 2019;25:2024\u201330. https:\/\/doi.org\/10.1016\/j.bbmt.2019.06.004.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1730_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41409-018-0266-6","volume":"54","author":"A Hakim","year":"2019","unstructured":"Hakim A, Cooke KR, Pavletic SZ, Khalid M, Williams KM, Hashmi SK. Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally. Bone Marrow Transpl. 2019;54:383\u201392. https:\/\/doi.org\/10.1038\/s41409-018-0266-6.","journal-title":"Bone Marrow Transpl"},{"key":"1730_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bmt.1703142","volume":"28","author":"B Afessa","year":"2001","unstructured":"Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transpl. 2001;28:425\u201334. https:\/\/doi.org\/10.1038\/sj.bmt.1703142.","journal-title":"Bone Marrow Transpl"},{"key":"1730_CR5","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1016\/j.chest.2021.01.008","volume":"159","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Wang C, Peters SG, Hogan WJ, Hashmi SK, Litzow MR, et al. Epidemiology, Risk Factors, and Outcomes of Diffuse Alveolar Hemorrhage After Hematopoietic Stem Cell Transplantation. Chest. 2021;159:2325\u201333. https:\/\/doi.org\/10.1016\/j.chest.2021.01.008.","journal-title":"Chest"},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s12185-019-02643-9","volume":"109","author":"Y Adachi","year":"2019","unstructured":"Adachi Y, Ozeki K, Ukai S, Sagou K, Fukushima N, Kohno A. Patterns of onset and outcome of cryptogenic organizing pneumonia after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2019;109:700\u201310. https:\/\/doi.org\/10.1007\/s12185-019-02643-9.","journal-title":"Int J Hematol"},{"key":"1730_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","volume":"183","author":"A Panoskaltsis-Mortari","year":"2011","unstructured":"Panoskaltsis-Mortari A, Griese M, Madtes DK, Belperio JA, Haddad IY, Folz RJ, et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med. 2011;183:1262\u201379. https:\/\/doi.org\/10.1164\/rccm.2007-413ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"1730_CR8","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1182\/blood-2014-12-617035","volume":"125","author":"S Seo","year":"2015","unstructured":"Seo S, Renaud C, Kuypers JM, Chiu CY, Huang ML, Samayoa E, et al. Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies. Blood. 2015;125:3789\u201397. https:\/\/doi.org\/10.1182\/blood-2014-12-617035.","journal-title":"Blood"},{"key":"1730_CR9","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s00277-019-03746-3","volume":"98","author":"KR Brownback","year":"2019","unstructured":"Brownback KR, Frey JW, Abhyankar S. Bronchoscopic features, associations, and outcomes of organizing pneumonia following allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2019;98:2187\u201395. https:\/\/doi.org\/10.1007\/s00277-019-03746-3.","journal-title":"Ann Hematol"},{"key":"1730_CR10","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571\u20136. https:\/\/doi.org\/10.1002\/art.21023.","journal-title":"Arthritis Rheum"},{"key":"1730_CR11","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;60:2193\u20132200. https:\/\/doi.org\/10.1002\/art.24621.","journal-title":"Arthritis Rheum"},{"key":"1730_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","volume":"49","author":"R Nakashima","year":"2010","unstructured":"Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, et al. The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatol (Oxf). 2010;49:433\u201340. https:\/\/doi.org\/10.1093\/rheumatology\/kep375.","journal-title":"Rheumatol (Oxf)"},{"key":"1730_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W, Guo L, Fu Y, Wang K, Zhang D, Xu W, et al. Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis. Clin Rev Allergy Immunol. 2021;60:293\u2013304. https:\/\/doi.org\/10.1007\/s12016-020-08822-5.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1730_CR14","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","volume":"51","author":"T Koga","year":"2012","unstructured":"Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri SY, Iwamoto N, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatol (Oxf). 2012;51:1278\u201384. https:\/\/doi.org\/10.1093\/rheumatology\/ker518.","journal-title":"Rheumatol (Oxf)"},{"key":"1730_CR15","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatol (Oxf). 2012;51:1563\u201370. https:\/\/doi.org\/10.1093\/rheumatology\/kes102.","journal-title":"Rheumatol (Oxf)"},{"key":"1730_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, et al. Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis. Arthritis Rheumatol. 2020;72:488\u201398. https:\/\/doi.org\/10.1002\/art.41105.","journal-title":"Arthritis Rheumatol"},{"key":"1730_CR17","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1093\/rheumatology\/keaa123","volume":"59","author":"M Shirakashi","year":"2020","unstructured":"Shirakashi M, Nakashima R, Tsuji H, Tanizawa K, Handa T, Hosono Y, et al. Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment. Rheumatol (Oxf). 2020;59:3284\u201392. https:\/\/doi.org\/10.1093\/rheumatology\/keaa123.","journal-title":"Rheumatol (Oxf)"},{"key":"1730_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/jamadermatol.2016.3976","volume":"153","author":"C Lepelletier","year":"2017","unstructured":"Lepelletier C, Bengoufa D, Lyes Z, de Masson A, Chasset F, Jachiet M, et al. Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation. JAMA Dermatol. 2017;153:184\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2016.3976.","journal-title":"JAMA Dermatol"},{"key":"1730_CR19","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/mus.26341","volume":"58","author":"J New-Tolley","year":"2018","unstructured":"New-Tolley J, Smith C, Koszyca B, Otto S, Maundrell A, Bardy P, et al. Inflammatory myopathies after allogeneic stem cell transplantation. Muscle Nerve. 2018;58:790\u20135. https:\/\/doi.org\/10.1002\/mus.26341.","journal-title":"Muscle Nerve"},{"key":"1730_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jaad.2017.12.010","volume":"78","author":"DJB Kurtzman","year":"2018","unstructured":"Kurtzman DJB, Vleugels RA. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol. 2018;78:776\u201385. https:\/\/doi.org\/10.1016\/j.jaad.2017.12.010.","journal-title":"J Am Acad Dermatol"},{"key":"1730_CR21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s10067-019-04457-w","volume":"38","author":"L Jiang","year":"2019","unstructured":"Jiang L, Wang Y, Peng Q, Shu X, Wang G, Wu X. Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody. Clin Rheumatol. 2019;38:1655\u201363. https:\/\/doi.org\/10.1007\/s10067-019-04457-w.","journal-title":"Clin Rheumatol"},{"key":"1730_CR22","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","volume":"158","author":"X Lian","year":"2020","unstructured":"Lian X, Zou J, Guo Q, Chen S, Lu L, Wang R, et al. Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease: The FLAIR Model. Chest. 2020;158:1535\u201345. https:\/\/doi.org\/10.1016\/j.chest.2020.04.057.","journal-title":"Chest"},{"key":"1730_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","volume":"121","author":"H Hozumi","year":"2016","unstructured":"Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, et al. Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Med. 2016;121:91\u201399. https:\/\/doi.org\/10.1016\/j.rmed.2016.10.019.","journal-title":"Respir Med"},{"key":"1730_CR24","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1093\/rheumatology\/keaa034","volume":"59","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Ye L, Liu M, Li S, Liu W, Chen F, et al. Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis. Rheumatology. 2020;59:2829\u201337. https:\/\/doi.org\/10.1093\/rheumatology\/keaa034.","journal-title":"Rheumatology"},{"key":"1730_CR25","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s10067-019-04918-2","volume":"39","author":"M Zhou","year":"2020","unstructured":"Zhou M, Ye Y, Yan N, Lian X, Bao C, Guo Q. Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis. Clin Rheumatol. 2020;39:1919\u201327. https:\/\/doi.org\/10.1007\/s10067-019-04918-2.","journal-title":"Clin Rheumatol"},{"key":"1730_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.semarthrit.2020.03.007","volume":"50","author":"F Romero-Bueno","year":"2020","unstructured":"Romero-Bueno F, Diaz Del Campo P, Trallero-Aragu\u00e1s E, Ruiz-Rodr\u00edguez JC, Castellvi I, Rodriguez-Nieto MJ, et al. Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. Semin Arthritis Rheum. 2020;50:776\u201390. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.007.","journal-title":"Semin Arthritis Rheum"},{"key":"1730_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang X, Ye S. Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease. N. Engl J Med. 2019;381:291\u20133. https:\/\/doi.org\/10.1056\/NEJMc1900045.","journal-title":"N. Engl J Med"},{"key":"1730_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","volume":"27","author":"AG Dias Junior","year":"2019","unstructured":"Dias Junior AG, Sampaio NG, Rehwinkel J. A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation. Trends Microbiol. 2019;27:75\u201385. https:\/\/doi.org\/10.1016\/j.tim.2018.08.007.","journal-title":"Trends Microbiol"},{"key":"1730_CR29","doi-asserted-by":"publisher","unstructured":"Nishina N, Sato S, Masui K, Gono T, Kuwana M Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease. RMD Open. 2020;6. https:\/\/doi.org\/10.1136\/rmdopen-2020-001202","DOI":"10.1136\/rmdopen-2020-001202"},{"key":"1730_CR30","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/ar3547","volume":"13","author":"Y Muro","year":"2011","unstructured":"Muro Y, Sugiura K, Hoshino K, Akiyama M, Tamakoshi K. Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan. Arthritis Res Ther. 2011;13:R214 https:\/\/doi.org\/10.1186\/ar3547.","journal-title":"Arthritis Res Ther"},{"key":"1730_CR31","doi-asserted-by":"publisher","first-page":"108628","DOI":"10.1016\/j.celrep.2020.108628","volume":"34","author":"X Yin","year":"2021","unstructured":"Yin X, Riva L, Pu Y, Martin-Sancho L, Kanamune J, Yamamoto Y, et al. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells. Cell Rep. 2021;34:108628 https:\/\/doi.org\/10.1016\/j.celrep.2020.108628.","journal-title":"Cell Rep"},{"key":"1730_CR32","doi-asserted-by":"publisher","first-page":"e107826","DOI":"10.15252\/embj.2021107826","volume":"40","author":"LG Thorne","year":"2021","unstructured":"Thorne LG, Reuschl AK, Zuliani-Alvarez L, Whelan MVX, Turner J, Noursadeghi M, et al. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. Embo J. 2021;40:e107826 https:\/\/doi.org\/10.15252\/embj.2021107826.","journal-title":"Embo J"},{"key":"1730_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92940-3","volume":"11","author":"NG Sampaio","year":"2021","unstructured":"Sampaio NG, Chauveau L, Hertzog J, Bridgeman A, Fowler G, Moonen JP, et al. The RNA sensor MDA5 detects SARS-CoV-2 infection. Sci Rep. 2021;11:13638 https:\/\/doi.org\/10.1038\/s41598-021-92940-3.","journal-title":"Sci Rep"},{"key":"1730_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","volume":"41","author":"P Mehta","year":"2021","unstructured":"Mehta P, Machado PM, Gupta L. Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. Rheumatol Int. 2021;41:1021\u201336. https:\/\/doi.org\/10.1007\/s00296-021-04819-1.","journal-title":"Rheumatol Int"},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11926-021-01023-9","volume":"23","author":"A Saud","year":"2021","unstructured":"Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and Myositis: What We Know So Far. Curr Rheumatol Rep. 2021;23:63 https:\/\/doi.org\/10.1007\/s11926-021-01023-9.","journal-title":"Curr Rheumatol Rep"},{"key":"1730_CR36","doi-asserted-by":"publisher","unstructured":"Giannini M, Ohana M, Nespola B, Zanframundo G, Geny B, Meyer A. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Eur Respir J. 2020;56. https:\/\/doi.org\/10.1183\/13993003.01618-2020","DOI":"10.1183\/13993003.01618-2020"},{"key":"1730_CR37","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1002\/art.34657","volume":"64","author":"T Gono","year":"2012","unstructured":"Gono T, Kawaguchi Y, Kuwana M, Sugiura T, Furuya T, Takagi K, et al. Brief report: Association of HLA-DRB1*0101\/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheum. 2012;64:3736\u201340. https:\/\/doi.org\/10.1002\/art.34657.","journal-title":"Arthritis Rheum"},{"key":"1730_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3899\/jrheum.160682","volume":"44","author":"S Moghadam-Kia","year":"2017","unstructured":"Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis. J Rheumatol. 2017;44:319\u201325. https:\/\/doi.org\/10.3899\/jrheum.160682.","journal-title":"J Rheumatol"},{"key":"1730_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjd.14882","volume":"176","author":"T Matsushita","year":"2017","unstructured":"Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, et al. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol. 2017;176:395\u2013402. https:\/\/doi.org\/10.1111\/bjd.14882.","journal-title":"Br J Dermatol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01730-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01730-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:04:03Z","timestamp":1744200243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01730-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,4]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1038\/s41409-022-01730-6","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,4]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}